Clinical Trial

A Study of HS-20094 in Overweight or Obese Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated July 10, 2025 (before its estimated February 4, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a multicenter, randomized, open-label, parallel clinical study to evaluate the bioequivalence of the HS-20094 MDV pen and AI pen in overweight or obese subjects.
Trial Details
NCT Number NCT07057674
Lead Sponsor Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions Overweight or Obesity
Enrollment 144 participants
Start Date 2025-04-16
Primary Completion 2026-02-04 (estimated)
Study Completion 2026-05-29 (estimated)
Updated on ClinicalTrials.gov 2025-07-10